U.S. markets close in 2 hours 28 minutes
  • S&P 500

    3,337.84
    -13.76 (-0.41%)
     
  • Dow 30

    27,450.11
    -133.95 (-0.49%)
     
  • Nasdaq

    11,100.50
    -17.02 (-0.15%)
     
  • Russell 2000

    1,496.65
    -13.69 (-0.91%)
     
  • Crude Oil

    38.98
    -1.62 (-3.99%)
     
  • Gold

    1,902.70
    +20.40 (+1.08%)
     
  • Silver

    24.44
    +0.84 (+3.56%)
     
  • EUR/USD

    1.1741
    +0.0073 (+0.62%)
     
  • 10-Yr Bond

    0.6430
    -0.0200 (-3.02%)
     
  • GBP/USD

    1.2851
    +0.0010 (+0.07%)
     
  • USD/JPY

    105.6600
    +0.1410 (+0.13%)
     
  • BTC-USD

    10,672.83
    -29.68 (-0.28%)
     
  • CMC Crypto 200

    228.58
    -1.09 (-0.47%)
     
  • FTSE 100

    5,897.50
    -30.43 (-0.51%)
     
  • Nikkei 225

    23,539.10
    +27.48 (+0.12%)
     

Trump’s drug importation plan faces resistance in U.S.

The Trump Administration announced its plan to allow states to import prescription drugs from Canada. The potential move is already facing headwinds from both U.S. pharmaceutical companies and the Canadian government. Yahoo Finance's Anjalee Khemlani joins the On the Move panel to discuss.